Elevated lipoprotein (a) levels predict deep vein thrombosis in acute ischemic stroke patients

NeuroReport

Volumn 27, Issue 1, 2016, Pages 39-44

  Yin, Dongliang ^a   Shao, Peng ^c   Liu, Yunling ^b  

^a Taishan Medical College   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^c YANTAISHAN HOSPITAL   (China)

Author keywords

Acute ischemic stroke; Deep vein thrombosis; Lipoprotein (a); Predictor

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; LIPOPROTEIN A;

ADULT; AGE; AGED; ARTICLE; BRAIN ISCHEMIA; CHINESE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; REFERENCE VALUE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; BLOOD; BLOOD ANALYSIS; CHINA; COLOR DOPPLER FLOWMETRY; ECHOGRAPHY; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STROKE; VENOUS THROMBOSIS;

AGED; BIOMARKERS; BLOOD CHEMICAL ANALYSIS; BRAIN ISCHEMIA; CHINA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STROKE; ULTRASONOGRAPHY, DOPPLER, COLOR; VENOUS THROMBOSIS;

EID: 84948710310     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0000000000000496     Document Type: Article

References (24)

1. Nordestgaard BG, Chapman MJ, Ray K, Borén J, Andreotti F, Watts GF, et al. Lipoprotein (a) as a cardiovascular risk factor: current status. Eur Heart J 2010; 31:2844-2853.
2. Smolders B, Lemmens R, Thijs V. Lipoprotein (a) and stroke a meta-analysis of observational studies. Stroke 2007; 38:1959-1966.
3. Samai AA, Monlezun DJ, Shaban A, George A, Cyprich J, El Khoury R, Martin-Schild S. Abstract W P160: elevated lipoprotein a levels predict worse short-term outcomes in acute ischemic stroke. Stroke 2015; 46 (Suppl 1):AWP160.
4. Zhang W, Zhang XA. Prognostic value of serum lipoprotein (a) levels in patients with acute ischemic stroke. Neuroreport 2014; 25:262-266.
5. Nave AH, Lange KS, Leonards CO, Siegerink B, Doehner W, Landmesser U, et al. Lipoprotein (a) as a risk factor for ischemic stroke: a meta-analysis. Atherosclerosis 2015; 242:496-503.
6. Nowak-Göttl U, Junker R, Hartmeier M, Koch H-G, Münchow N, Assmann G, von Eckardstein A. Increased lipoprotein (a) is an important risk factor for venous thromboembolism in childhood. Circulation 1999; 100:743-748.
7. Marcucci R, Liotta AA, Cellai AP, Rogolino A, Gori AM, Giusti B, et al. Increased plasma levels of lipoprotein (a) and the risk of idiopathic and recurrent venous thromboembolism. Am J Med 2003; 115:601-605.
8. Lippi G, Bassi A, Brocco G, Manzato F, Marini M, Guidi G. Lipoprotein (a) concentration is not associated with venous thromboembolism in a case-control study. Haematologica 1999; 84:726-729.
9. Vormittag R, Vukovich T, Stain M, Lehr S, Minar E, Pabinger I. Lipoprotein (a) in patients with spontaneous venous thromboembolism. Thromb Res 2007; 120:15-20.
10. Ogata T, Yasaka M, Wakugawa Y, Inoue T, Ibayashi S, Okada Y. Deep venous thrombosis after acute intracerebral hemorrhage. J Neurol Sci 2008; 272:83-86.
11. de Freitas GR, Nagayama M. Deep venous thrombosis after intracerebral hemorrhage, gender and ethnicity: a challenge for therapeutic approaches. Cerebrovasc Dis 2009; 27:320-321.
12. Lacut K, Bressollette L, Le Gal G, Etienne E, De Tinteniac A, Renault A, et al. Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology 2005; 65:865-869.
13. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989; 20:864-870.
14. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST: trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24:35-41.
15. Sims JR, Gharai LR, Schaefer PW, Vangel M, Rosenthal ES. ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology 2009; 72:2104-2110.
16. Tapson VF, Carroll BA, Davidson BL, Elliott CG, Fedullo PF, Hales CA, et al. The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic Society. Am J Respir Crit Care Med 1999; 160:1043-1066.
17. Skaf E, Stein PD, Beemath A, Sanchez J, Bustamante MA, Olson RE. Venous thromboembolism in patients with ischemic and hemorrhagic stroke. Am J Cardiol 2005; 96:1731-1733.
18. Ogata T, Yasaka M, Wakugawa Y, Kitazono T, Okada Y. Association of deep venous thrombosis with calf vein diameter in acute hemorrhagic stroke. J Stroke Cerebrovasc Dis 2013; 22:1002-1005.
19. von Depka M, Nowak-Göttl U, Eisert R, Dieterich C, Barthels M, Scharrer I, et al. Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism. Blood 2000; 96:3364-3368.
20. Ogunyemi D, Cuellar F, Ku W, Arkel Y. Association between inherited thrombophilias, antiphospholipid antibodies, and lipoprotein A levels and venous thromboembolism in pregnancy. Am J Perinatol 2003; 20:17-24.
21. van der PT, Buller HR, ten Cate H, Wortel CH, Bauer KA, van Deventer SJ, et al. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 1990; 322:1622-1627.
22. Wakefield TW, Greenfield LJ, Rolfe MW, DeLucia A 3rd, Strieter RM, Abrams GD, et al. Inflammatory and procoagulant mediator interactions in an experimental baboon model of venous thrombosis. Thromb Haemost 1993; 69:164-172.
23. Berglund L, Ramakrishnan R. Lipoprotein(a): an elusive cardiovascular risk factor. Arterioscler Thromb Vasc Biol 2004; 24:2219-2226.
24. Dangas G, Mehran R, Harpel PC, Sharma SK, Marcovina SM, Dube G, et al. Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation. J Am Coll Cardiol 1998; 32:2035-2042.